Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003469982 | SCV004191141 | likely pathogenic | Chédiak-Higashi syndrome | 2024-02-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003469982 | SCV004474755 | pathogenic | Chédiak-Higashi syndrome | 2023-02-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with LYST-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu2379Profs*30) in the LYST gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LYST are known to be pathogenic (PMID: 9215679, 11857544). |